BP000268-CHM-244: Recombinant Human GROγ (CXCL3), His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000268-CHM-255: Recombinant Mouse GROγ (CXCL3)
Source: E. coli-derived.
Determined by its ability to chemoattract 293 transfected CXCR2 cells using a concentration range of 10-100 ug/ml, corresponding to a specific activity of 10,000-100,000 units/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000268-CHM-258: Recombinant Rat GROγ (CXCL3), CINC-2 alpha
Source: E. coli-derived.
Determined by its ability to chemoattract 293 transfected CXCR2 cells using a concentration range of 10-100 ug/ml, corresponding to a specific activity of 10,000-100,000 units/mg.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000268-CHM-273: Recombinant Rat GROγ (CXCL3), CINC-2 beta
Source: E. coli-derived.
Determined by its ability to chemoattract human CXCR2 transfected 293 cells using a concentration range of 10-100 ug/ml.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000268-CHM-283: Recombinant Mouse GROγ (CXCL3), His Tag
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE.BP000268-CHM-310: Recombinant Human GROγ (CXCL3)
Source: E. coli-derived.
The Biological activity is calculated by its ability to chemoattract CXCR2 transfected 293 cells using 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 98%, by SDS-PAGE and RP-HPLC.